scispace - formally typeset
G

Gordon H. Guyatt

Researcher at McMaster University

Publications -  1749
Citations -  262329

Gordon H. Guyatt is an academic researcher from McMaster University. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 231, co-authored 1620 publications receiving 228631 citations. Previous affiliations of Gordon H. Guyatt include Memorial Sloan Kettering Cancer Center & Cayetano Heredia University.

Papers
More filters
Journal ArticleDOI

Creating Clinical Practice Guidelines We Can Trust, Use, and Share : A New Era Is Imminent

TL;DR: MAGIC as mentioned in this paper is a conceptual framework and tools to facilitate the creation, dissemination, and dynamic updating of trustworthy clinical practice guidelines, which can facilitate face-to-face shared decision-making in the clinical encounter.
Journal ArticleDOI

How can quality of life researchers make their work more useful to health workers and their patients

TL;DR: Reporting approaches that allow investigators to use the same strategies in reporting pooled estimates from meta-analyses, even when studies use different instruments to measure the same construct will also help those developing decision aids to use quality of life data.
Journal ArticleDOI

Pressure and Volume Limited Ventilation for the Ventilatory Management of Patients with Acute Lung Injury: A Systematic Review and Meta-Analysis

TL;DR: This systematic review and meta-analysis of randomized controlled trials comparing pressure and volume-limited (PVL) ventilation strategies with more traditional mechanical ventilation in adults with ALI and ARDS suggests that PVL strategies for mechanical ventilation with traditional approaches to ventilation in critically ill adults with AlI andARDS reduce mortality and are associated with increased use of paralytic agents.
Journal ArticleDOI

A new 'Mechanistic-Practical” Framework for designing and interpreting randomized trials

TL;DR: A revised framework facilitates investigators' choice of optimal trial design, and clinicians' optimal interpretation of RCT results, by introducing two terms that refer explicitly to the purpose of a trial: A trial is mechanistic to the extent that it addresses a biological relationship and a trial is practical to the amount of comprehensive information that bears directly on specific health care decisions.